Literature DB >> 12052062

Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors.

Ali Ozuer1, James B Wechuck, Brian Russell, Darren Wolfe, William F Goins, Joseph C Glorioso, Mohammad M Ataai.   

Abstract

Herpes simplex virus type-1 (HSV-1) is a neurotrophic human pathogen that establishes life-long latency in the nervous system. Our laboratory has extensively engineered this virus to retain the ability to persist in neurons without expression of lytic genes or disease phenotype. Highly defective, replication-incompetent HSV mutants are thus potentially ideal for transfer of therapeutic transgenes to human nerves where long-term therapy of nervous system disease may be provided. A prerequisite for using recombinant HSV vectors for therapeutic gene delivery to humans is the development of methods for large-scale manufacture of HSV vectors. Here we report studies to identify infection parameters that result in high-yield production of immediate early gene deletion mutant HSV vectors in complementing cells that supply the deleted essential viral functions in trans. Virus yield was correlated with various culture media conditions that included pH, glucose metabolism, and serum levels. The results demonstrated that systematic media exchange to remove lactate derived from high-level glucose consumption, maintenance of tissue culture pH at 6.8, and the use of 5% fetal bovine serum gave the highest yield of infectious virus. The data indicate that these are important parameters to consider for high-yield, large-scale virus production.

Entities:  

Mesh:

Year:  2002        PMID: 12052062     DOI: 10.1021/bp010176k

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

Review 1.  Large-scale adeno-associated viral vector production using a herpesvirus-based system enables manufacturing for clinical studies.

Authors:  Nathalie Clément; David R Knop; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

2.  Morphological changes in different populations of bladder afferent neurons detected by herpes simplex virus (HSV) vectors with cell-type-specific promoters in mice with spinal cord injury.

Authors:  Nobutaka Shimizu; Mark F Doyal; William F Goins; Katsumi Kadekawa; Naoki Wada; Anthony J Kanai; William C de Groat; Akihide Hirayama; Hirotsugu Uemura; Joseph C Glorioso; Naoki Yoshimura
Journal:  Neuroscience       Date:  2017-09-20       Impact factor: 3.590

3.  Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin.

Authors:  Hitoshi Yokoyama; Katsumi Sasaki; Michael E Franks; William F Goins; James R Goss; William C de Groat; Joseph C Glorioso; Michael B Chancellor; Naoki Yoshimura
Journal:  Hum Gene Ther       Date:  2009-01       Impact factor: 5.695

Review 4.  Gene therapy as future treatment of erectile dysfunction.

Authors:  Naoki Yoshimura; Ryuichi Kato; Michael B Chancellor; Joel B Nelson; Joseph C Glorioso
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

5.  Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury.

Authors:  R Kato; D Wolfe; C H Coyle; J B Wechuck; P Tyagi; T Tsukamoto; J B Nelson; J C Glorioso; M B Chancellor; N Yoshimura
Journal:  Gene Ther       Date:  2008-07-31       Impact factor: 5.250

6.  Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification.

Authors:  Canping Jiang; James B Wechuck; William F Goins; David M Krisky; Darren Wolfe; Mohammad M Ataai; Joseph C Glorioso
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Aurintricarboxylic acid increases yield of HSV-1 vectors.

Authors:  Peter Pechan; Jeffery Ardinger; Jyothi Ketavarapu; Hillard Rubin; Samuel C Wadsworth; Abraham Scaria
Journal:  Mol Ther Methods Clin Dev       Date:  2014-02-19       Impact factor: 6.698

8.  Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early Genes.

Authors:  Seiji Kuroda; Yoshitaka Miyagawa; Yuriko Sato; Motoko Yamamoto; Kumi Adachi; Hiromi Kinoh; William F Goins; Justus B Cohen; Joseph C Glorioso; Nobuhiko Taniai; Hiroshi Yoshida; Takashi Okada
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-17       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.